These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
862 related articles for article (PubMed ID: 19595306)
1. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Jiang BH; Liu LZ Adv Cancer Res; 2009; 102():19-65. PubMed ID: 19595306 [TBL] [Abstract][Full Text] [Related]
2. PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Ma J; Sawai H; Ochi N; Matsuo Y; Xu D; Yasuda A; Takahashi H; Wakasugi T; Takeyama H Mol Cell Biochem; 2009 Nov; 331(1-2):161-71. PubMed ID: 19437103 [TBL] [Abstract][Full Text] [Related]
3. PI3K/PTEN signaling in tumorigenesis and angiogenesis. Jiang BH; Liu LZ Biochim Biophys Acta; 2008 Jan; 1784(1):150-8. PubMed ID: 17964232 [TBL] [Abstract][Full Text] [Related]
4. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Fang J; Ding M; Yang L; Liu LZ; Jiang BH Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033 [TBL] [Abstract][Full Text] [Related]
5. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy. Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996 [TBL] [Abstract][Full Text] [Related]
6. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis. Joshi S; Singh AR; Zulcic M; Durden DL Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499 [TBL] [Abstract][Full Text] [Related]
7. Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway. Park JH; Lee JY; Shin DH; Jang KS; Kim HJ; Kong G Oncogene; 2011 Nov; 30(45):4578-89. PubMed ID: 21602890 [TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway. Cheng S; Zhang X; Feng Q; Chen J; Shen L; Yu P; Yang L; Chen D; Zhang H; Sun W; Chen X Life Sci; 2019 Jun; 227():82-93. PubMed ID: 31004658 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis regulator through modulating IAP expression (ARIA) controls the PI3K/Akt pathway in endothelial and endothelial progenitor cells. Koide M; Ikeda K; Akakabe Y; Kitamura Y; Ueyama T; Matoba S; Yamada H; Okigaki M; Matsubara H Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9472-7. PubMed ID: 21593423 [TBL] [Abstract][Full Text] [Related]
10. The PTEN⁻PI3K Axis in Cancer. Papa A; Pandolfi PP Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30999672 [TBL] [Abstract][Full Text] [Related]
11. Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer. Yan Y; Huang H Adv Exp Med Biol; 2019; 1210():319-331. PubMed ID: 31900915 [TBL] [Abstract][Full Text] [Related]
12. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis. Newton HB Expert Rev Anticancer Ther; 2004 Feb; 4(1):105-28. PubMed ID: 14748662 [TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model. Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425 [TBL] [Abstract][Full Text] [Related]
15. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453 [TBL] [Abstract][Full Text] [Related]
16. PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations. Kar S; Samii A; Bertalanffy H Neurosurg Rev; 2015 Apr; 38(2):229-36; discussion 236-7. PubMed ID: 25403688 [TBL] [Abstract][Full Text] [Related]
17. PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells. Tian T; Nan KJ; Wang SH; Liang X; Lu CX; Guo H; Wang WJ; Ruan ZP Carcinogenesis; 2010 Jul; 31(7):1211-9. PubMed ID: 20430845 [TBL] [Abstract][Full Text] [Related]
18. The role of PI3K/AKT/FOXO signaling in psoriasis. Zhang M; Zhang X Arch Dermatol Res; 2019 Mar; 311(2):83-91. PubMed ID: 30483877 [TBL] [Abstract][Full Text] [Related]
19. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas. Nozhat Z; Hedayati M Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586 [TBL] [Abstract][Full Text] [Related]
20. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]